Price movement over the last 24 hours
AdaptHealth Corp vs A O Smith Corp — how do they compare? AdaptHealth Corp trades at $10.01 (market cap $1.38B), while A O Smith Corp trades at $59.82 (market cap $8.45B). The key difference: A O Smith Corp is far larger — about 6.1× AdaptHealth Corp's market cap, and A O Smith Corp pays a 2.32% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | AOS | |
|---|---|---|
Market Cap | $1.38B | $8.45B |
Sector | Health | Industrials |
52-Week High | $13.38 | $80.47 |
52-Week Low | $8.68 | $55.78 |
Enterprise Value | $3.33B | $8.90B |
Dividend Yield | — | 2.32% |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
A.O. Smith (AOS) trades at $61.31, down 2.25% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company reported a Q1 2026 earnings miss ($0.85 actual vs. $0.94 expected) but maintains strong profitability with a 13.84% net margin and 28.27% ROE. Recent leadership changes include CEO Stephen Shafer becoming chairman as of July 1, 2026 (PRNewswire, June 22, 2026).
The stock shows mixed signals: solid fundamentals and a $68 consensus price target suggest upside, but recent earnings weakness and repeated Zacks Strong Sell ratings (June 18, 2026) indicate near-term headwinds. Investors face risks from China market softness and competitive pressures, though cash flow stability and dividend payments provide support.
Trailing returns across standard periods
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →A.O. Smith Corporation manufactures and markets comprehensive lines of residential and commercial gas, gas tankless, and electric water heaters. Supplementary products include water heating equipment, condensing and noncondensing boilers, and water system tanks. The company's two operating segments are by geographic region: North America (majority of total revenue) and the Rest of the World. A material portion of sales in North America derive from replacing existing products, and the company utilizes a wholesale distribution channel and multiple selling locations. The Rest of the World segment sells primarily to Asian countries and operates sales offices to expand distribution and market its product portfolio.
Read more on AOS →